FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

19 letters match. Newest first.

  1. Lakpura LLC

    FDA and Federal Trade Commission warned Lakpura LLC over ayurvedic products and teas with unapproved COVID-19 claims.

    High risk
  2. Bespoke Apothecary LLC

    Bespoke Apothecary sold COVID kit and herbal tea with unapproved COVID-19 treatment claims, FDA and FTC say.

    Low
  3. FluxxLab LLC

    FDA and FTC warned FluxxLab that its COVID-19 and CBDA/CBD tinctures are unapproved, misbranded drugs marketed with unsupported COVID-19 claims.

    High risk
  4. Klarity Kratom

    Klarity Kratom sold kratom products as unapproved drugs claiming they treat opioid addiction, FDA and FTC say.

    High risk
  5. MONQ, LLC

    MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.

    High risk
  6. Sensory Cloud, Inc

    FDA and FTC warn Sensory Cloud that its FEND nasal mister is an unapproved, misbranded drug sold with COVID-19 prevention and treatment claims.

    High risk
  7. Functional Remedies, LLC D/B/A Synchronicity Hemp Oil

    FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.

    High risk
  8. Greenway Herbal Products LLC

    FDA and FTC warned GreenWay Herbal Products that CBD website claims to prevent and treat COVID-19 make its products unapproved, misbranded drugs.

    High risk
  9. Cureganics

    Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.

    High risk
  10. Nature's Highway

    FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.

    High risk
  11. Pharmaganics LLC

    FDA and FTC warn Pharmaganics over diabetes supplement claims that make unapproved, misbranded drugs.

    High risk
  12. Phytag Labs

    FDA and FTC warn Phytag Labs that its GLUCOTYPE2 supplement is an unapproved drug and misbranded due to diabetes treatment claims.

    Medium
  13. Nuturna International LLC

    Nuturna International marketed 'Diabetic Support Formula' with diabetes-treatment claims, making it an unapproved drug and misbranded.

    High risk
  14. Lysulin, Inc.

    Lysulin, Inc. marketed diabetes and weight-loss supplements as unapproved drugs and misbranded products.

    High risk
  15. Holistic Healer & Wellness Center, Inc.

    FDA and FTC warned Holistic Healer & Wellness Center that Diabalance Diabetes Supplement claims make it an unapproved new drug.

    High risk
  16. Beauty & Spa Concepts, DBA Beenefits

    FDA and FTC warned Beauty & Spa Concepts, DBA Beenefits, over unapproved, misbranded Brazilian Propolis Extract sold with COVID-19 prevention and treatment claims.

    High risk
  17. Fertility Nutraceuticals LLC

    FDA and FTC told Fertility Nutraceuticals its three fertility supplements are unapproved drugs because of disease-treatment claims online and in shipping inserts.

    High risk
  18. Allure Imports

    Allure Imports sold unapproved Silver Soul and Vitality C60 products claimed to treat COVID-19.

    High risk
  19. About Mineral

    FDA and FTC warn About Mineral that its Puriton skin products are unapproved drugs with misleading COVID-19 claims.

    High risk